BCG treatment in Tis of the urinary bladder, results of the EORTC Protocol 30861. EORTC GU Group

Prog Clin Biol Res. 1992;378:69-74.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • BCG Vaccine / administration & dosage
  • BCG Vaccine / adverse effects
  • BCG Vaccine / therapeutic use*
  • Carcinoma in Situ / therapy*
  • Carcinoma, Transitional Cell / therapy
  • Clinical Protocols
  • Cystitis / etiology
  • Humans
  • Middle Aged
  • Prospective Studies
  • Tuberculin Test
  • Urinary Bladder Neoplasms / therapy*

Substances

  • BCG Vaccine